Point72 Asset Management
ALNA

Point72 Asset Management’s Allena Pharmaceuticals ALNA Stock Holding History

Point72 Asset Management’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,000,000
Closed -$3.9M – 1301
2021
Q2 		$3.9M Hold
3,000,000
– – 0.02% 651
2021
Q1 		$4.17M Sell
3,000,000
-1,000,000
-25% -$1.67M 0.02% 603
2020
Q4 		$5.12M Buy
+4,000,000
New +$5.58M 0.03% 576

Other funds holding ALNA

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Point72 Asset Management's ALNA Position: Q3 2021 in Review

Point72 Asset Management sold out of Allena Pharmaceuticals (ALNA) in Q3 2021, closing a stake of 3,000,000 shares — an estimated $3.9M sold.

Point72 Asset Management first reported a position in ALNA in Q4 2020 and held it in 3 quarters. The position peaked at $5.12M in Q4 2020. 36 funds tracked by Wall St. Rank hold ALNA as of Q3 2021.

  • Point72 Asset Management reported no remaining Allena Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Point72 Asset Management sold 3,000,000 Allena Pharmaceuticals shares in Q3 2021, an estimated $3.9M.
  • Point72 Asset Management first reported a position in Allena Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Point72 Asset Management's Allena Pharmaceuticals position peaked at $5.12M in Q4 2020.
  • 36 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2021.

Based on Point72 Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.